weight loss

Allergan's Lap-Band, a device implanted in the stomach to limit the amount of food that can be ingested, is already on the market to help the very obese lose weight. But now the company hopes to win approval for less obese patients to use the band.

Weight Watchers International (WTW) unveiled the successor to its iconic calorie-counting Points program. The new PointsPlus program will not only identify the number of calories in a foodstuff but also favor food that the body works harder to convert into energy and steer the weight-conscious away...

Dieters looking for a little extra willpower to avoid putting junk food in their grocery carts might want to leave their credit cards at home. New research shows that buying groceries with plastic instead of good old-fashioned folding money makes people more likely to buy unhealthy foods.

Drug and medical-device maker Abbott Laboratories announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia, (sibutramine) from the U.S. market at the request of the FDA, due to concerns it increases the risk of heart attacks and strokes.

The N.J. Supreme Court gave a win to advocates of truth in advertising this week when it ruled that lawsuits against the maker of dietary supplement Relacore could go forward as a class action. Considering the way such lawsuits work, gaining that status is almost as important as the final verdict.

The New England Journal of Medicine called Meridia "another flawed diet pill" -- two weeks before government advisers are scheduled to review the drug -- after a study finds it raises the risk of heart attack and stroke in users with heart problems.

As many as 1 million U.S. consumers could have been scammed out of up to $100 million with acai berry and colon cleaners with phony endorsements from Rachael Ray and Oprah Winfrey, the U.S. Federal Trade Commission said. The FTC announced it has sued the Arizona company making the claims and that a...

J & H Besta Corp. is recalling one lot of its herbal diet supplement after U.S. Food and Drug Administration tests showed the weight-loss pill contained an undeclared appetite suppressant known to increase blood pressure and heart rate in some users. Slim-20 Herb Supplement in 30-capsule...

Pharmaceutical company Vivus is getting hammered in Friday tading, sinking more than 50% in the wake of Thursday's vote by an FDA advisory panel against approving its weight-loss drug, Qnexa, based on safety concerns.

Pharmaceutical company Vivus and investors waited anxiously Thursday for the vote of an FDA advisory panel on the weight-loss drug Qnexa. The verdict is in, and by a vote of 9 to 7, panelists didn't support approving the drug as an obesity treatment.